...
首页> 外文期刊>Research in Pharmaceutical Sciences >Protective effects of glucosamine and its acetylated derivative on serum/glucose deprivation-induced PC12 cells death: Role of reactive oxygen species
【24h】

Protective effects of glucosamine and its acetylated derivative on serum/glucose deprivation-induced PC12 cells death: Role of reactive oxygen species

机译:氨基葡萄糖及其乙酰化衍生物对血清/葡萄糖剥夺诱导的PC12细胞死亡的保护作用:活性氧的作用

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Finding products with antiapoptotic activities has been one of the approaches for the treatment of neurodegenerative disorders. Serum/glucose deprivation (SGD) has been used as a model for the investigation of the molecular mechanisms of neuronal ischemia. Recent studies indicated that glucosamine (GlcN) and N-acetyl glucosamine (GlcNAc) have many pharmacological effects including antioxidant activities. The present study aimed to investigate the protective effects of GlcN and GlcNAc against SGD-induced PC12 cells injury. The PC12 cells were pretreated with GlcN and GlcNAc for 2 h, and then exposed to SGD for 6, 12 and 24 h. Cell viability was evaluated by MTT assay. The level of intracellular reactive oxygen species (ROS) was determined by flow cytometry using 2',7'- dichlorofluorescin diacetate (DCFH-DA) as a probe. SGD condition caused a significant reduction in cell survival after 6, 12, and 24 h ( P < 0.001). Pretreatment with GlcN and GlcNAc (0.6-20 mM) increased cell viability following SGD insult. A significant increase in cell apoptosis was observed in cells under SGD condition after 12 h ( P < 0.001). Pretreatment with GlcN and GlcNAc (5-20 mM) decreased apoptosis following SGD condition after 12 h. SGD resulted in a significant increase in intracellular ROS production after 12 h. Pretreatment with both amino sugars at concentrations of 10 to 20 mM could reverse the ROS increment. Results indicated that GlcN and GlcNAc had a cytoprotective property against SGD-induced cell death via anti-apoptosis and antioxidant activities, suggesting that these aminosugers have the potential to be used as novel therapeutic agents for neurodegenerative disorders.
机译:寻找具有抗凋亡活性的产品已成为治疗神经变性疾病的方法之一。血清/葡萄糖剥夺(SGD)已用作研究神经元缺血的分子机制的模型。最近的研究表明,葡糖胺(GlcN)和N-乙酰基葡糖胺(GlcNAc)具有许多药理作用,包括抗氧化活性。本研究旨在研究GlcN和GlcNAc对SGD诱导的PC12细胞损伤的保护作用。 PC12细胞用GlcN和GlcNAc预处理2小时,然后暴露于SGD 6、12和24小时。通过MTT测定法评估细胞活力。使用2',7'-二氯荧光素二乙酸盐(DCFH-DA)作为探针,通过流式细胞术确定细胞内活性氧(ROS)的水平。 SGD条件导致6、12和24小时后细胞存活率显着降低(P <0.001)。 SGD损伤后,用GlcN和GlcNAc(0.6-20 mM)预处理可提高细胞活力。在12小时后,在SGD条件下的细胞中观察到细胞凋亡的显着增加(P <0.001)。用SGcN和GlcNAc(5-20​​ mM)预处理可降低SGD条件后12 h的凋亡。 12小时后,SGD导致细胞内ROS的产生显着增加。用两种氨基糖以10至20 mM的浓度进行预处理可以逆转ROS的增加。结果表明,GlcN和GlcNAc具有通过抗凋亡和抗氧化活性来抵抗SGD诱导的细胞死亡的细胞保护特性,这表明这些氨基糖有潜力用作神经退行性疾病的新型治疗剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号